Choroid, lens, and vitreous

Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods

Volumn , Issue , 2001, Pages 161-193

  Smith, Richard S ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44949145785     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (147)

1. Smith, R.S. and Trokel, S., Effects of mast cell degranulation on the choroid, Arch. Ophthalmol., 75: 390, 1966.
2. Wilson, J.G., Roth, C.B., and Warkany, J., An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation, Am. J. Anat., 92: 189, 1953.
3. Lohnes, D. et al., Function of the retinoic acid receptors (RARs) during development: (I) Craniofacial and skeletal abnormalities in RAR double mutants, Development, 120: 2723, 1994.
4. Mendelsohn, C. et al., Function of the retinoic acid receptors (RARs) during development: (II) Multiple abnormalities at various stages of organogenesis in RAR double mutants, Development, 120: 2479, 1994.
5. Kastner, P. et al., Genetic analysis of RXRαdevelopmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis, Cell, 78: 987, 1994.
6. Grondona, J.M. et al., Retinal dysplasia and degeneration in RARbeta2/RARgamma2 compound mutant mice, Development, 122: 2173, 1996.
7. Smith, R.S., Roderick, T.H., and Sundberg, J.P., Microphthalmia and associated abnormalities in inbred black mice, Lab. Animal Sci., 44: 551, 1994.
8. Ozeki, H. and Shirai, S., Developmental eye abnormalities in mouse fetuses induced by retinoic acid, Jpn. J. Ophthalmol., 12: 162, 1998.
9. Cook, C.S., Nowotney, A.Z., and Sulik, K.K., Fetal alcohol syndrome: eye malformations in a mouse model, Arch. Ophthalmol., 105: 1576, 1987.
10. White, J.G., Structural defects in inherited and giant platelet disorders, Adv. Hum. Genet., 199019: 133.
11. Boissy, R.E. and Nordlund, J.J., Molecular basis of congenital hypopigmentary disorders in humans: a review, Pigment Cell Res., 10: 12, 1997.
12. Barbosa, M. et al., Identifications of mutations in two major mRNA isoforms in the Chediak-Higashi syndrome gene in human and mouse, Hum. Mol. Genet., 6: 1091, 1997.
13. Oetting, W.S. and King, R.A., Molecular basis of albinism: mutations and polymorphisms of pigmentation associated with albinism, Human Mut., 13: 99, 1999.
14. Gwynn, B. et al., A gene on mouse chromosome 5 and human 4p encodes a protein critical for organelle biogenesis, Blood, 96: 4227, 2000.
15. Robison, W.G., Kuwabara, T., and Cogan, D.G., Lysosomes and melanin granules of the retinal pigment epithelium in a mouse model of the Chediak-Higashi syndrome, Invest. Ophthalmol. Vis. Sci., 14: 312, 1975.
16. Mangini, N.J. et al., The optokinetic nystagmus and ocular pigmentation of hypopigmented mouse mutants, J. Comp. Neurol., 241: 191, 1985.
17. Collier, L.L., Prieur, D.J., and King, E.J., Ocular melanin pigmentation anomalies in cats, cattle, mink, and mice with Chediak-Higashi syndrome: histologic observations, Curr. Eye Res., 3: 1241, 1984.
18. Ito, M., Hashimoto, K., and Organisciak, D.T., Ultrastructural, histochemical and biochemical studies of the melanin metabolism in pallid mouse eye, Curr. Eye Res., 2: 13, 1983.
19. Robison, W.G. and Kuwabara, T., Light-induced alterations of retinal pigment epithelium in black, albino, and beige mice, Exp. Eye Res., 22: 549, 1976.
20. Swank, R.T. et al., Mouse models of Hermansky Pudlak syndrome: a review, Pigment Cell Res., 11: 60, 1998.
21. Gibb, S. et al., Reduced pigmentation (rp), a new coat colour gene with effects on kidney lysosomal glycosidases in the mouse, Genet. Res., 37: 96, 1981.
22. Novak, E.K. et al., Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation, Blood, 85: 1781, 1995.
23. Lindquist, N.G. et al., Age-related melanogenesis in the eye of mice, studied by microautoradiography of 3H-methimazole, a specific marker of melanin synthesis, Exp. Eye Res., 67: 759, 1998.
24. Moyer, F.H., Genetic variations in the fine structure and ontogeny of mouse melanin granules, Am. Zool., 6: 43, 1966.
25. Mouse Genome Informatics Project, Mouse Genome Database (MGD), 2001.
26. Packer, S.O., The eye and skeletal effects of two mutant alleles at the microphthalmia locus of Mus musculus, J. Exp. Zool., 165: 21, 1967.
27. Scholtz, C.L. and Chan, K.K., Complicated colobomatous microphthalmia in the micropthalmic (mi/mi) mouse, Development, 99: 501, 1987.
28. Hodgkinson, C.A. et al., Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein, Cell, 74: 395, 1993.
29. Steingrimsson, E. et al., Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences, Nat. Genet., 8: 256, 1994.
30. Boissy, R.E., Moellmann, G.E., and Lerner, A.B., Morphology of melanocytes in hair bulbs and eyes of vitiligo mice, Am. J. Pathol., 127: 380, 1987.
31. Boissy, R.E. et al., Ocular pathology in mice with a transgenic insertion at the microphthalmia locus, J. Submicrosc. Cytol. Pathol., 25: 319, 1993.
32. Tassabehjii, M., Newton, V.E., and Read, A.P., Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene, Nat. Genet., 8: 251, 1994.
33. Spencer, W.H., Ed., Ophthalmic Pathology: An Atlas and Textbook, 4th ed., W.B. Saunders, Philadelphia, 1996.
34. Brito, B.Z. et al., Murine endotoxin-induced uveitis, but not immune complex-induced uveitis, is dependent on the IL-8 receptor homolog, Curr. Eye Res., 19: 76, 1999.
35. Geiger, K. et al., Transgenic mice expressing IFN-γin the retina develop inflammation of the eye and photoreceptor loss, Invest. Ophthalmol. Vis. Sci., 35: 2667, 1994.
36. McMenamin, P.G., Dendritic cells and macrophages in the uveal tract of the normal mouse eye, Br. J. Ophthalmol., 83: 598, 1999.
37. Caspi, R.R. et al., A new model of autoimmune disease: experimental autoimmune uveoretinitis induced in mice with two different retinal antigens, J. Immunol., 140: 1490, 1988.
38. Caspi, R.R. et al., The mouse as a model of experimental autoimmune uveoretinitis (EAU), Curr. Eye Res., 9: 169, 1990.
39. Jiang, H., Lumsden, L., and Forrester, J.V., Macrophages and dendritic cells in IRPB-induced experimental autoimmune uveoretinitis in B10RIII mice, Invest. Ophthalmol. Vis. Sci., 40: 3177, 1999.
40. Howes, E.L. et al., Cellular and vascular responses in acute experimental ocular inflammation, Invest. Ophthalmol. Vis. Sci., 35: 4031, 1994.
41. Li, G. and Peng, B. et al., Endotoxin induced uveitis in the mouse: susceptibility and genetic control, Exp. Eye Res., 61: 629, 1995.
42. Caspi, R.R. et al., Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis, Curr. Eye Res., 11: 81, 1992.
43. Whittum, J.A. et al., Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus, Invest. Ophthalmol. Vis. Sci., 25: 1065, 1984.
44. Anderson, J.R. and Field, H.J., An animal model of ocular herpes. Keratitis, retinitis and cataract in the mouse, Br. J. Exp. Pathol., 65: 283, 1984.
45. Li, W. et al., Bilateral retinal responses during the acute phase (4-14 days) after traumatization of a single eye in the mouse, Eur. J. Morphol., 32: 49, 1994.
46. Lutty, G.A. et al., Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease, Am. J. Pathol., 145: 490, 1994.
47. Lutty, G. et al., Nonperfusion of the retina and choroid in transgenic mouse models of sickle cell disease, Curr. Eye Res., 17: 438, 1998.
48. Nakamura, A. et al., Ocular fundus lesions in systemic lupus erythematosus model mice, Jpn. J. Ophthalmol., 42: 345, 1998.
49. Klein, R. et al., The Wisconsin epidemiologic study of diabetic retinopathy, Arch. Ophthalmol., 112: 1217, 1994.
50. Retinal Diseases Panel, Vision Research, A National Plan: 1999-2003, U.S. Department of Health and Human Services, Washington, D.C., 1999.
51. Guyer, D.R. et al., Subfoveal choroidal neovascular membranes in age-related macular degeneration, Arch. Ophthalmol., 104: 702, 1986.
52. Tobe, T. et al., Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model, Am. J. Pathol., 153: 1641, 1998.
53. Kaplan, H.J. et al., Fas ligand (CD95 ligand) controls angiogenesis beneath the retina, Nat. Med., 5: 292, 1999.
54. Kimura, H. et al., Cellular response to subretinal neovascularization induced by bFGF-impregnated microspheres, Invest. Ophthalmol. Vis. Sci., 40: 524, 1999.
55. Aiello, L.P. et al., Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins, Proc. Natl. Acad. Sci. U.S.A., 92: 10457, 1995.
56. Aiello, L., Vascular endothelial growth factor, Invest. Ophthalmol. Vis. Sci., 38: 1647, 1997.
57. Baffi, J. et al., Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor, Invest. Ophthalmol. Vis. Sci., 41: 3582, 2000.
58. Okamoto, N. et al., Transgenic mice with increased expression of vascular endothelial growth factor in the retina, Am. J. Pathol., 151: 281, 1997.
59. Hinton, D.R., Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration, Arch. Ophthalmol., 116: 203, 1998.
60. Fishman, G.A. et al., Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene, Arch. Ophthalmol., 117: 504, 1999.
61. Smith, R.S. et al., The Bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization, Proc. Natl. Acad. Sci. U.S.A., 97: 2191, 2000.
62. Slusher, M.M. et al., The spectrum of cavitary optic disc anomalies in a family, Ophthalmology, 96: 342, 1989.
63. Hayashi, N., Valdes-Dapena, M., and Green, W.R., CHARGE association: histopathological report of two cases and a review, J. Pediatr. Ophthalmol. Strab., 35: 100, 1998.
64. Kenyon, B.M. et al., A model of angiogenesis in the mouse cornea, Invest. Ophthalmol. Vis. Sci., 37: 1625, 1996.
65. Gimbrone, M.A. et al., Tumor angiogenesis: iris neovascularization at a distance from experimental tumors, J. Natl. Cancer Inst., 50: 219, 1973.
66. Ma, D. et al., Rejection of intraocular tumors from transgenic mice by tumor-infiltrating lymphocytes, Curr. Eye Res., 13: 361, 1994.
67. Casey, R. and Li, W.W., Factors controlling ocular angiogenesis, Am. J. Ophthalmol., 124: 521, 1997.
68. Pattengale, P.K. and Taylor, C.R., Experimental models of lymphoproliferative disease, Am. J. Pathol., 113: 237, 1983.
69. Tadesse-Heath, L. and Morse, H.C., Lymphomas in genetically engineered mice, in Ward, J.M. et al., Eds., Pathology of Genetically Engineered Mice, Iowa State University Press, Ames, 2000, 365.
70. He, W. et al., A reassessment of histologic classification and an immunohistochemical study of 88 retinoblastomas, Cancer, 70: 2901, 1992.
71. Yuge, K. et al., Immunohistochemical features of the human retina and retinoblastoma, Virchows Arch., 426: 571, 1995.
72. Windle, J. et al., Retinoblastoma in transgenic mice, Nature, 343: 665, 1990.
73. Brandt, C.R. et al., Treatment of spontaneously arising retinoblastoma tumors in transgenic mice with an attenuated herpes simplex virus mutant, Virology, 229: 283, 1997.
74. Marcus, D.M. et al., Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen, Invest. Ophthalmol. Vis. Sci., 37: 392, 1996.
75. Bradl, M. et al., Malignant melanoma in transgenic mice, Proc. Natl. Acad. Sci. U.S.A., 88: 164, 1991.
76. Mintz, B., Silvers, W.K., and Klein-Szanto, A., Histopathogenesis of malignant skin melanoma induced in genetically susceptible transgenic mice, Proc. Natl. Acad. Sci. U.S.A., 90: 8822, 1993.
77. Anand, R. et al., Characterization of intraocular tumors arising in transgenic mice, Invest. Ophthalmol. Vis. Sci., 35: 3533, 1994.
78. Syed, N.A. et al., Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment, Invest. Ophthalmol. Vis. Sci., 39: 2800, 1998.
79. Penna, D., Schmidt, A., and Beerman, F., Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice, Oncogene, 17: 2601, 1998.
80. Zhu, H. et al., Development of heritable melanoma in transgenic mice, J. Invest. Dermatol., 110: 247, 1998.
81. Beermann, F., The tyrosinase related protein-1 (Tyrp1) promoter in transgenic experiments: targeted expression in the retinal pigmented epithelium, Cell. Mol. Biol., 45: 961, 1999.
82. Mintz, B. and Klein-Szanto, A., Malignancy of eye melanomas originating in the retinal pigment epithelium of transgenic mice after genetic ablation of choroidal melanocytes, Proc. Natl. Acad. Sci. U.S.A., 89: 11421, 1992.
83. Iwamoto, T. et al., Aberrent melanogenesis and melanocytic tumor development in transgenic mice that carry a metallothionein/ret fusion gene, EMBO J., 10: 3167, 1991.
84. Schmidt, A. et al., Ectopic expression of RET results in microphthalmia and tumors in the retinal pigment epithelium, Int. J. Cancer, 80: 600, 1999.
85. Beerman, F., Hunziker, A., and Foletti, A., Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium, Pigment Cell Res., 12: 71, 1999.
86. John, S.W.M.J. et al., Essential iris atrophy, pigment dispersion and glaucoma in DBA/2J mice, Invest. Ophthalmol. Vis. Sci., 39: 951, 1998.
87. Anderson, M.G. et al., Genetic modifications of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice, BMC Genet., 2: 1, 2001.
88. Chang, B. et al., Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice, Nat. Genet., 21: 405, 1999.
89. Collinson, J.M., Hill, R.E., and West, J.D., Different roles for Pax6 in the optic vesicle and facial epithelium mediate early morphogenesis of the murine eye, Development, 127: 945, 2000.
90. Desplan, C., Eye development: governed by a dictator or a junta? Cell, 91: 861, 1997.
91. Fini, M.E., Strissel, K.J., and West-Mays, J.A., Perspectives on eye development, Dev. Genet., 20: 175, 1997.
92. van Raamsdonk, C.D. and Tilghman, S.M., Dosage requirements and allelic expression of PAX6 during lens placode formation, Development, 127: 5439, 2000.
93. Schwarz, M. et al., Spatial specification of mammalian eye territories by reciprocal transcriptional repression of Pax2 and Pax6, Development, 127: 4325, 2000.
94. Robison, W.G., Kuwabara, T., and Zwaan, J., Eye research, in Foster, H.L., Small, J.D., and Fox, J.G., Eds., The Mouse in Biomedical Research, Academic Press, New York, 1982, 80.
95. Smith, R.S., Sundberg, J.P., and Linder, C.C., Mouse mutations as models for studying cataracts, Pathobiology, 65: 146, 1997.
96. Graw, J., Genetic aspects of embryonic eye development in vertebrates, Dev. Genet., 18: 181, 1996.
97. Schedl, A. et al., Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities, Cell, 86: 71, 1996.
98. Quinn, J.C., West, J.D., and Hill, R.E., Multiple functions for Pax6 in mouse eye and nasal development, Genes Dev., 10: 435, 1996.
99. Kuck, J.F.R., Late onset hereditary cataract of the Emory mouse. A model for human senile cataract, Exp. Eye Res., 50: 659, 1990.
100. Hosokawa, M. et al., Persistent hyaloid vascular system in age-related cataract in a SAM strain of mouse, Exp. Eye Res., 57: 427, 1993.
101. Ashida, Y., Takeda, T., and Hosokawa, M., Protein alterations in age-related cataract associated with a persistent hyaloid vascular system in senescence-accelerated mouse (SAM), Exp. Eye Res., 59: 467, 1994.
102. Li, Y., Yan, Q., and Wolf, N.S., Long-term caloric restriction delays age-related decline in proliferation capacity of murine lens epithelial cells in vitro and in vivo, Invest. Ophthalmol. Vis. Sci., 38: 100, 1997.
103. Smith, R.S. et al., Lop12, a mutation in mouse Crygd causing lens opacity similar to human Coppock cataract, Genomics, 63: 314, 2000.
104. Smith, R.S. et al., Cataract and neurological abnormalities in partial trisomy, Invest. Ophthalmol. Vis. Sci., 38: S585, 1997.
105. Reneker, L.W. and Overbeek, P.A., Lens-specific expression of PDGF-A in transgenic mice results in retinal astrocytic hamartomas, Invest. Ophthalmol. Vis. Sci., 37: 2455, 1996.
106. West, J.D. and Fisher, G., Further experience of the mouse dominant cataract mutation test from an experiment with ethylnitrosourea, Mutant Res., 1986 164: 127.
107. Varnum, D., Nuclear cataract (nuc), Mouse News Lett., 64: 59, 1981.
108. Graw, J. et al., Characterization of Cat-2, a radiation-induced dominant cataract mutation in mice, Invest. Ophthalmol. Vis. Sci., 31: 1353, 1990.
109. Lyon, M.F. et al., Further genetic analysis of two autosomal dominant mouse eye defects, Ccw and Pax6coop, Mol. Vis., 6: 199, 2000.
110. Beasley, A.B., Inheritance and development of a lens abnormality in the mouse, J. Morphol., 112: 1, 1963.
111. Fraser, F.C. and Herer, M.L., The inheritance and expression of the “lens rupture” gene in the house mouse, J. Hered., 41: 3, 1950.
112. Fraser, F.C. and Herer, M.L., Lens rupture, a new recessive gene in the house mouse, J. Hered., 39: 149, 1948.
113. Runge, P.E. et al., Autosomal dominant mouse cataract (Lop-10): consistent differences of expression in heterozygotes, Invest. Ophthalmol. Vis. Sci., 33: 3202, 1992.
114. Griep, A.E. et al., Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation, J. Virol., 67: 1373, 1993.
115. Gotz, W. et al., Eye pathology in transgenic mice carrying a MSV-SV 40 large T-construct, Exp. Eye Res., 52: 41, 1991.
116. Pichel, J.G., Lakso, M., and Westphal, H., Timing of SV40 oncogene activation by site-specific recombination determines subsequent tumor progression during murine lens development, Oncogene, 8: 3333, 1993.
117. Mahon, K.A. et al., Oncogenesis of the lens in transgenic mice, Science, 235: 1622, 1987.
118. Oliver, G. and Gruss, P., Current views on eye development, Trends Neurosci., 20: 415, 1997.
119. Dahl, E., Koseki, H., and Balling, R., Pax genes and organogenesis, Bioessays, 19: 755, 1997.
120. Grimes, P.A. et al., Abnormal eye development associated with Cat4a, a dominant mouse cataract mutation on chromosome 8, Invest. Opthalmol. Sci., 39: 1863, 1998.
121. Kaufman, M.H., Chang, H.H., and Shaw, J.P., Craniofacial abnormalities in homozygous small eye (Sey/Sey) embryos, J. Anat., 186: 607, 1995.
122. Tomita, K. et al., Mammalian hairy and enhancer of split homolog-1 regulates differentiation of retinal neurons and is essential for eye morphogenesis, Neuron, 16: 723, 1996.
123. Hui, C. et al., Expression of three mouse homologs of the Drosophila segment polarity gene cubitus interruptus, Gli, Gli-2, and Gli-3, in ectoderm- and mesoderm-derived tissues suggests multiple roles during postimplantation development, Dev. Biol., 162: 402, 1994.
124. Burmeister, M. et al., Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiation, Nat. Genet., 12: 376, 1996.
125. Grimm, C. et al., Aphakia (ak), a mouse mutation affecting early eye development: fine mapping, consideration of candidate genes and altered Pax6 and Six3 gene expression pattern, Dev. Genet., 23: 299, 1998.
126. Aso, S.S.H. and Noda, S., Lens aplasia: a new mutation producing lens abnormality in the mouse, Lab. Animal Sci., 45: 41, 1995.
127. Hogan, M.J., Alvarado, J.A., and Weddell, J.E., Histology of the Human Eye, W.B. Saunders, Philadelphia, 1971.
128. Lang, R. et al., Apoptosis during macrophage-dependent ocular tissue remodeling, Development, 120: 3395, 1994.
129. Lang, R.A. and Bishop, J.M., Macrophages are required for cell death and tissue remodeling in the developing mouse eye, Cell, 74: 453, 1993.
130. Ito, M. and Yoshioka, M., Regression of the hyaloid vessels and pupillary membrane of the mouse, Anat. Embryol. Berl., 200: 403, 1999.
131. Ihanamaki, T. et al., Ocular abnormalities in transgenic mice harboring mutations in the type II collagen gene, Eur. J. Ophthalmol., 6: 427, 1996.
132. Goldberg, M.F., Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous, Am. J. Ophthalmol., 124: 587, 1997.
133. Merlino, G., Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice, Semin. Canc. Biol., 5: 13, 1994.
134. Rak, J., Filmus, J., and Kerbel, R.S., Reciprocal paracrine interactions between tumor cells and endothelial cells: the “angiogenesis progression” hypothesis, Eur. J. Cancer, 32A: 2438, 1996.
135. Stellmach, V. et al., Tumor suppressor genes and angiogenesis: the role of TP53 in fibroblasts, Eur. J. Cancer, 32A: 2394, 1996.
136. Sah, V.P. et al., A subset of p53-deficient embryos exhibit exencephaly, Nat. Genet., 10: 175, 1995.
137. Pan, H. and Griep, A.E., Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development, Genes Dev., 9: 157, 1995.
138. Ikeda, S. et al., Ocular abnormalities in C57BL/6 but not 129/Sv p53 deficient mice, Invest. Ophthalmol. Vis. Sci., 40: 1874, 1999.
139. Berger, W., Molecular dissection of Norrie disease, Acta Anat., 162: 95, 1998.
140. Berger, W. et al., An animal model for Norrie disease (ND): gene targeting of the mouse ND gene, Hum. Mol. Genet., 5: 51, 1996.
141. Ruether, K. et al., Retinoschisis-like alterations in the mouse eye caused by gene targeting of the Norrie disease gene, Invest. Ophthalmol. Vis. Sci., 38: 710, 1997.
142. Richter, M. et al., Retinal vasculature changes in Norrie disease mice, Invest. Ophthalmol. Vis. Sci., 39: 2450, 1998.
143. Valleix, S. et al., Expression of human F8B, a gene nested with the coagulation factor VIII gene, produces multiple eye defects and developmental alterations in chimeric and transgenic mice, Hum. Mol. Genet., 8: 1291, 1999.
144. Egwuagu, C.E. et al., Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC Class II gene expression, Invest. Ophthalmol. Vis. Sci., 35: 332, 1994.
145. Egwuagu, C.E. et al., γInterferon expression disrupts lens and retinal differentiation in transgenic mice, Dev. Biol., 166: 557, 1994.
146. Ghyselinck, N.B. et al., Role of the retinoic acid receptor beta (RARβ) during mouse development, Int. J. Dev. Biol., 41: 425, 1997.
147. Ozeki, H. et al., Critical period for retinoic acid-induced developmental abnormalities of the vitreous in mouse fetuses, Exp. Eye Res., 68: 223, 1999.